Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.

Wargent E, Stocker C, Augstein P, Heinke P, Meyer A, Hoffmann T, Subramanian A, Sennitt MV, Demuth HU, Arch JR, Cawthorne MA.

Diabetes Obes Metab. 2005 Mar;7(2):170-81.

PMID:
15715890
2.

Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation.

Wargent E, Sennitt MV, Stocker C, Mayes AE, Brown L, O'Dowd J, Wang S, Einerhand AW, Mohede I, Arch JR, Cawthorne MA.

Lipids Health Dis. 2005 Jan 10;4:3.

3.

Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice.

Schmid GM, Converset V, Walter N, Sennitt MV, Leung KY, Byers H, Ward M, Hochstrasser DF, Cawthorne MA, Sanchez JC.

Proteomics. 2004 Aug;4(8):2270-82.

PMID:
15274121
4.

Modulation of susceptibility to weight gain and insulin resistance in low birthweight rats by treatment of their mothers with leptin during pregnancy and lactation.

Stocker C, O'Dowd J, Morton NM, Wargent E, Sennitt MV, Hislop D, Glund S, Seckl JR, Arch JR, Cawthorne MA.

Int J Obes Relat Metab Disord. 2004 Jan;28(1):129-36.

PMID:
14557827
5.

Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice.

Sanchez JC, Converset V, Nolan A, Schmid G, Wang S, Heller M, Sennitt MV, Hochstrasser DF, Cawthorne MA.

Proteomics. 2003 Aug;3(8):1500-20.

PMID:
12923776
6.

Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice.

Sanchez JC, Converset V, Nolan A, Schmid G, Wang S, Heller M, Sennitt MV, Hochstrasser DF, Cawthorne MA.

Mol Cell Proteomics. 2002 Jul;1(7):509-16.

7.

Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.

Liu YL, Sennitt MV, Hislop DC, Crombie DL, Heyman RA, Cawthorne MA.

Int J Obes Relat Metab Disord. 2000 Aug;24(8):997-1004.

PMID:
10951538
8.

The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle.

Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD, Park J, Chambers J, Sennitt MV, Stock MJ, Cawthorne MA, Young PW, Murphy GJ.

Int J Obes Relat Metab Disord. 1999 Oct;23(10):1057-65.

PMID:
10557026
9.

The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.

Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J, Chapman H, Henson SM, Berge JM, Dean DK, Kotecha NR, Morgan HK, Rami HK, Ward RW, Thompson M, Wilson S, Smith SA, Cawthorne MA, Stock MJ, Arch JR.

J Pharmacol Exp Ther. 1998 Jun;285(3):1084-95. Erratum in: J Pharmacol Exp Ther 1998 Dec;287(3):1135.

PMID:
9618411
10.

The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344.

Oriowo MA, Chapman H, Kirkham DM, Sennitt MV, Ruffolo RR Jr, Cawthorne MA.

J Pharmacol Exp Ther. 1996 Apr;277(1):22-7.

PMID:
8613923
11.

The beta-adrenoceptor selectivity profile of BRL 37344 in the pithed rat.

Oriowo MA, Sennitt MV, Smith SA, Ruffolo RR Jr, Cawthorne MA.

J Auton Pharmacol. 1994 Oct;14(5):337-44.

PMID:
7829538
12.

SK&F 104078, a post-junctionally selective alpha 2-adrenoceptor antagonist in the human saphenous vein in vitro.

Roberts SP, Kelly J, Cawthorne MA, Sennitt MV.

Naunyn Schmiedebergs Arch Pharmacol. 1992 Mar;345(3):327-32.

PMID:
1352382
13.

BRL 35135, a potent and selective atypical beta-adrenoceptor agonist.

Cawthorne MA, Sennitt MV, Arch JR, Smith SA.

Am J Clin Nutr. 1992 Jan;55(1 Suppl):252S-257S. doi: 10.1093/ajcn/55.1.252s. Review.

PMID:
1345889
14.

Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830.

Carroll MJ, Lister CA, Sennitt MV, Stewart-Long N, Cawthorne MA.

Diabetes. 1985 Nov;34(11):1198-204.

PMID:
2864298
15.

Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.

Smith SA, Levy AL, Sennitt MV, Simson DL, Cawthorne MA.

Biochem Pharmacol. 1985 Jul 15;34(14):2425-9.

PMID:
2861816
16.

Effect of a novel thermogenic beta-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats.

Challiss RA, Budohoski L, Newsholme EA, Sennitt MV, Cawthorne MA.

Biochem Biophys Res Commun. 1985 Apr 30;128(2):928-35.

PMID:
2986630
17.

Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.

Sennitt MV, Arch JR, Levy AL, Simson DL, Smith SA, Cawthorne MA.

Biochem Pharmacol. 1985 Apr 15;34(8):1279-85.

PMID:
2859857
18.

Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs.

Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S.

Nature. 1984 May 10-16;309(5964):163-5.

PMID:
6325935
19.

The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists.

Wilson C, Wilson S, Piercy V, Sennitt MV, Arch JR.

Eur J Pharmacol. 1984 May 4;100(3-4):309-19.

PMID:
6145597
20.

Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.

Cawthorne MA, Carroll MJ, Levy AL, Lister CA, Sennitt MV, Smith SA, Young P.

Int J Obes. 1984;8 Suppl 1:93-102.

PMID:
6152558
21.
22.

Vitamin E and hepatotoxic agents. 3. Vitamin E, synthetic antioxidants and carbon tetrachloride toxicity in the rat.

Cawthorne MA, Bunyan J, Sennitt MV, Green J, Grasso P.

Br J Nutr. 1970 Jun;24(2):357-84. No abstract available.

PMID:
5452694

Supplemental Content

Loading ...
Support Center